Citation Impact
Citing Papers
Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD mice
2004
An engineered 4-1BBL fusion protein with “activity on demand”
2020
Dendritic cell–expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice
2007 StandoutNobel
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
2022 StandoutNobel
Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity
2013 StandoutScience
Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8 + T cells in NOD mice
2008 StandoutNobel
CD40 Agonist Antibodies in Cancer Immunotherapy
2019
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression
2021 StandoutNobel
Dietary Reference Intakes for Calcium and Vitamin D
2011 Standout
Genetic Disassociation of Autoimmunity and Resistance to Costimulation Blockade-Induced Transplantation Tolerance in Nonobese Diabetic Mice
2003
The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy
2023
Target-conditioned diffusion generates potent TNFR superfamily antagonists and agonists
2024 StandoutScienceNobel
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
2020 Standout
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Phenotypic and Functional Characteristics of BM-Derived DC from NOD and Non-Diabetes-Prone Strains
2001
Protective role for cytosolic phospholipase A2α in autoimmune diabetes of mice
2005
Pathogenesis of Sjögren's Syndrome: Characteristics of Different Mouse Models for Autoimmune Exocrinopathy
2002
Features of the dendritic cell lineage
2010 StandoutNobel
Immune cell crosstalk in type 1 diabetes
2010
Cytokine–receptor interactions as drug targets
2010
Genes and Cellular Requirements for Autoimmune Diabetes Susceptibility in Nonobese Diabetic Mice
2001
Back to Central Tolerance
2004 Standout
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Significance of TIM3 expression in cancer: From biology to the clinic
2019
Chemokines
2000 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Sunlight and Vitamin D
2013 Standout
Changes in the Expression of Nephrin Gene and Protein in Experimental Diabetic Nephropathy
2001
Cell‐intrinsic effects of non‐MHC NOD genes on dendritic cell generation in vivo
2002
Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia–reperfusion injury
2007
Fms-like tyrosine kinase 3 ligand administration overcomes a genetically determined dendritic cell deficiency in NOD mice and protects against diabetes development
2005
Role of dendritic cells in the induction and maintenance of autoimmune diseases
1999
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity
2016
Local Expression of TNFα in Neonatal NOD Mice Promotes Diabetes by Enhancing Presentation of Islet Antigens
1998
Connecting Type 1 and Type 2 Diabetes through Innate Immunity
2012
The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity
2006 StandoutNobel
TFOS DEWS II pathophysiology report
2017 Standout
Sensors of the innate immune system: their link to rheumatic diseases
2010 StandoutNobel
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Receptor‐mediated endocytosis of iron‐oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging
2003
Iron oxide MR contrast agents for molecular and cellular imaging
2004 Standout
Some active areas of DC research and their medical potential
2010 StandoutNobel
Regulation of autoimmune diabetes by non‐islet‐specific T cells — a role for the glucocorticoid‐induced TNF receptor
2004 StandoutNobel
The advent of de novo proteins for cancer immunotherapy
2020
Type 1 diabetes
2013 Standout
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression
2021 StandoutNobel
Controlled Microwave Heating in Modern Organic Synthesis
2004 Standout
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
2008 StandoutNature
An introduction to chimeric antigen receptor (CAR) T‐cell immunotherapy for human cancer
2019
The Complex Role of Estrogens in Inflammation
2007 Standout
Multifaceted Activities of Type I Interferon Are Revealed by a Receptor Antagonist
2014 StandoutNobel
Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes
2005 StandoutNobel
Cell Biology of the Glomerular Podocyte
2003 Standout
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
Increased Generation of Dendritic Cells from Myeloid Progenitors in Autoimmune-Prone Nonobese Diabetic Mice
2002
Activated NKT Cells Inhibit Autoimmune Diabetes through Tolerogenic Recruitment of Dendritic Cells to Pancreatic Lymph Nodes
2005
Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor
2004 StandoutNobel
Immunobiology of DC in NOD mice
1999
Desiccating Stress Induces T Cell-Mediated Sjogren’s Syndrome-Like Lacrimal Keratoconjunctivitis
2006 Standout
Altered phenotype and function of dendritic cells in children with type 1 diabetes
2005
Molecular Pathways: Activating T Cells after Cancer Cell Phagocytosis from Blockade of CD47 “Don't Eat Me” Signals
2015
Diversity, Mechanisms, and Significance of Macrophage Plasticity
2019 Standout
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
Dendritic Cells from Nonobese Diabetic Mice Exhibit a Defect in NF-κB Regulation Due to a Hyperactive IκB Kinase
2001
Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
2020
Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice.
2000
CD4+ T Cells from Glutamic Acid Decarboxylase (GAD)65-specific T Cell Receptor Transgenic Mice Are Not Diabetogenic and Can Delay Diabetes Transfer
2002
Initiation of Autoimmune Diabetes by Developmentally Regulated Presentation of Islet Cell Antigens in the Pancreatic Lymph Nodes
1999
Islet-Specific Th1, But Not Th2, Cells Secrete Multiple Chemokines and Promote Rapid Induction of Autoimmune Diabetes
1999
Vitamin D and Immune Function
2013 Standout
Differential MHC Class II Presentation of a Pathogenic Autoantigen during Health and Disease
2006
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2band dose-dependent requirement of H-2g7for diabetes in NOD mice
2008 StandoutNobel
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
2008
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
2016
Molecular Mechanisms for Gender Differences in Susceptibility to T Cell-Mediated Autoimmune Diabetes in Nonobese Diabetic Mice
2002
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Intrinsic in vitro abnormalities in dendritic cell generation caused by non‐MHC non‐obese diabetic genes
2002
Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells
2000 StandoutNobel
Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of β cells
2007 StandoutNobel
CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune Diabetes
2004 StandoutNobel
The Biology of Chemokines and their Receptors
2000 Standout
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
An efficient route from coumarins to highly functionalized N-phenyl-2-quinolinones via Buchwald–Hartwig amination
2003
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Works of Eva Dahlén being referenced
The Human Agonistic CD40 Antibody ADC-1013 Eradicates Bladder Tumors and Generates T-cell–Dependent Tumor Immunity
2014
Development of Interleukin-1 Receptor Antagonist Mutants with Enhanced Antagonistic ActivityIn Vitroand Improved Therapeutic Efficacy in Collagen-Induced Arthritis
2008
Bispecific antibodies in cancer immunotherapy
2018
Inhibition of Autoimmune Disease by the Immunomodulator Linomide Correlates with the Ability to Activate Macrophages
2000
Low CD86 Expression in the Nonobese Diabetic Mouse Results in the Impairment of Both T Cell Activation and CTLA-4 Up-Regulation
2000
Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse.
1998
Abstract A183: ATOR-1017: A 4-1BB antibody designed for superior safety/efficacy profile in cancer immunotherapy
2019
Dendritic Cells and Macrophages Are the First and Major Producers of TNF-α in Pancreatic Islets in the Nonobese Diabetic Mouse
1998